Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $143.62 billion. The enterprise value is $154.39 billion.
| Market Cap | 143.62B |
| Enterprise Value | 154.39B |
Important Dates
The last earnings date was Wednesday, October 22, 2025, before market open.
| Earnings Date | Oct 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 0.71% in one year.
| Current Share Class | 1.48B |
| Shares Outstanding | 1.48B |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 93.50% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 51.81 and the forward PE ratio is 29.23. BSX's PEG ratio is 1.77.
| PE Ratio | 51.81 |
| Forward PE | 29.23 |
| PS Ratio | 7.40 |
| Forward PS | 6.55 |
| PB Ratio | 6.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 37.56 |
| P/OCF Ratio | 31.05 |
| PEG Ratio | 1.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.45, with an EV/FCF ratio of 40.37.
| EV / Earnings | 55.32 |
| EV / Sales | 7.98 |
| EV / EBITDA | 30.45 |
| EV / EBIT | 41.50 |
| EV / FCF | 40.37 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.51 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.33 |
| Debt / FCF | 3.15 |
| Interest Coverage | 10.97 |
Financial Efficiency
Return on equity (ROE) is 12.49% and return on invested capital (ROIC) is 6.85%.
| Return on Equity (ROE) | 12.49% |
| Return on Assets (ROA) | 5.76% |
| Return on Invested Capital (ROIC) | 6.85% |
| Return on Capital Employed (ROCE) | 9.95% |
| Revenue Per Employee | $365,075 |
| Profits Per Employee | $52,660 |
| Employee Count | 53,000 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, BSX has paid $486.00 million in taxes.
| Income Tax | 486.00M |
| Effective Tax Rate | 14.86% |
Stock Price Statistics
The stock price has increased by +7.44% in the last 52 weeks. The beta is 0.67, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +7.44% |
| 50-Day Moving Average | 98.99 |
| 200-Day Moving Average | 101.71 |
| Relative Strength Index (RSI) | 39.64 |
| Average Volume (20 Days) | 8,250,688 |
Short Selling Information
The latest short interest is 19.45 million, so 1.31% of the outstanding shares have been sold short.
| Short Interest | 19.45M |
| Short Previous Month | 19.40M |
| Short % of Shares Out | 1.31% |
| Short % of Float | 1.32% |
| Short Ratio (days to cover) | 2.11 |
Income Statement
In the last 12 months, BSX had revenue of $19.35 billion and earned $2.79 billion in profits. Earnings per share was $1.87.
| Revenue | 19.35B |
| Gross Profit | 13.22B |
| Operating Income | 3.72B |
| Pretax Income | 3.27B |
| Net Income | 2.79B |
| EBITDA | 5.07B |
| EBIT | 3.72B |
| Earnings Per Share (EPS) | $1.87 |
Balance Sheet
The company has $1.28 billion in cash and $12.05 billion in debt, giving a net cash position of -$10.77 billion or -$7.27 per share.
| Cash & Cash Equivalents | 1.28B |
| Total Debt | 12.05B |
| Net Cash | -10.77B |
| Net Cash Per Share | -$7.27 |
| Equity (Book Value) | 23.63B |
| Book Value Per Share | 15.78 |
| Working Capital | 2.71B |
Cash Flow
In the last 12 months, operating cash flow was $4.63 billion and capital expenditures -$802.00 million, giving a free cash flow of $3.82 billion.
| Operating Cash Flow | 4.63B |
| Capital Expenditures | -802.00M |
| Free Cash Flow | 3.82B |
| FCF Per Share | $2.58 |
Margins
Gross margin is 68.33%, with operating and profit margins of 19.23% and 14.43%.
| Gross Margin | 68.33% |
| Operating Margin | 19.23% |
| Pretax Margin | 16.90% |
| Profit Margin | 14.43% |
| EBITDA Margin | 26.21% |
| EBIT Margin | 19.23% |
| FCF Margin | 19.76% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.71% |
| Shareholder Yield | -0.71% |
| Earnings Yield | 1.94% |
| FCF Yield | 2.66% |
Analyst Forecast
The average price target for BSX is $124.53, which is 28.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $124.53 |
| Price Target Difference | 28.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 12.54% |
| EPS Growth Forecast (5Y) | 32.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 5.55 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.55 |
| Piotroski F-Score | 6 |